ArticleAsian journal of urology2026
Transcriptome-wide association study of prostate cancer in the Chinese population.
Article in Asian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Prostate cancer (PCa) is among the most prevalent malignancies in men, with a substantial genetic predisposition. Despite extensive genome-wide association studies (GWAS) identifying numerous risk loci, the causal target genes remain largely undetermined. To address this knowledge gap, we conducted the first transcriptome-wide association study (TWAS) of PCa in the Chinese population to systematically identify putative target genes. Methods: This study included 5048 participants, comprising 2425 individuals from the Chinese Prostate Cancer Genetics Consortium cohort (1417 PCa cases and 1008 healthy controls) and 2623 from the Ruijin Biopsy cohort (1133 cases and 1490 controls). We employed both single-tissue and cross-tissue TWAS approaches to prioritize candidate genes. Causal inference was performed using two-sample Mendelian randomization, while differential mRNA expression and methylation analyses were conducted to investigate potential regulatory mechanisms. The prognostic significance of the identified genes was further assessed through survival analysis. Results: A total of 179 and 114 putative target genes were identified in the ChinaPCa and Ruijin Biopsy cohorts, respectively. The meta-analysis of the single-tissue TWAS revealed 23 genes achieving false discovery rate significance, while cross-tissue TWAS identified nine additional significant genes (one gene previously reported in the single-tissue TWAS was excluded). GRAM domain-containing protein 2 ( Conclusion: This study represents the first comprehensive TWAS of PCa in the Chinese population, identifying 290 putative causal genes. These findings enhance our understanding of PCa pathogenesis and may inform future research on molecular mechanisms, therapeutic targets, and prognostic biomarkers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.